Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
FEMALE
NCT07025213

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Led by National Institute of Cancerología · Updated on 2025-06-17

80

Participants Needed

1

Research Sites

195 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: Endometrial cancer is one of the diseases linked to obesity in women. In Mexico, about 7.6 women out of every 100,000 are diagnosed with this type of cancer, and nearly three-quarters of these women have obesity. Many women with endometrial cancer also have a condition called sarcopenic obesity, where muscle loss happens but might not be easy to identify. Researchers believe that certain molecules in the blood could help identify the health of muscles. Exercise helps muscles stay strong and healthy by affecting these molecules. For women with cancer, staying active can help maintain muscle mass, which is important for better recovery and health outcomes. This project focuses on an exercise program for women with locally advanced endometrial cancer who will be treated surgically at the National Cancer Institute of Mexico (INCan). What We Think Will Happen: Women with endometrial cancer who participate in a program combining physical activity and healthy eating will gain more muscle strength and function compared to those who don't exercise. We expect these changes to be connected to healthier levels of certain molecules in the blood, showing less muscle breakdown and less inflammation. We also believe these women will have better control of blood sugar and fats. Our Main Goal: To find out how physical activity and diet affect muscle health and metabolism in women with endometrial cancer, and to compare these changes to women who don't participate in the exercise program. How We Will Do It: We will measure molecules related to muscle health in the blood. We will also assess muscle size, strength, and how well the muscles work. Then, we will look for connections between these muscle changes and the blood molecules. We want to see if improvements in muscle are linked to better recovery from surgery and better health outcomes. If so, these blood molecules might help doctors monitor muscle health. We hope that the exercise program will help women recover better and improve their quality of life. How We Will Analyze the Data: We will describe the data we collect and compare the group that exercises to the group that doesn't. We will use statistics to see if the differences are meaningful. We will also analyze the relationship between muscle health and blood markers. Advanced methods will help us identify which molecules and measurements best explain the changes seen. The results will be carefully reviewed using specialized software. What We Hope to Find: We aim to show that blood tests can help identify muscle health and how it improves with exercise. This could lead to earlier detection of muscle loss and better management through exercise programs. Ultimately, this work hopes to improve the health and well-being of women facing endometrial cancer.

CONDITIONS

Official Title

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Who Can Participate

Age: 18Years - 65Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to understand the study and provide written consent
  • Women aged over 18 and under 65 years
  • Availability to attend exercise sessions
  • Willingness and ability to follow scheduled visits, diet, treatment, and lab tests
  • Histologically confirmed diagnosis of endometrioid-type endometrial cancer by biopsy
  • Normal electrocardiogram (ECG) result
  • No prior oncological treatment
  • Body mass index (BMI) greater than 20 kg/m²
  • Availability of a computed tomography (CT) scan
  • Candidates for staging surgery
Not Eligible

You will not qualify if you...

  • Advanced clinical stage or stage IVB disease (FIGO 2018 criteria)
  • Prior or concurrent malignancy except non-melanoma skin cancer
  • Uncontrolled systemic arterial hypertension
  • Renal dysfunction (eGFR ≤ 60 mL/min/1.73 m²)
  • Uncontrolled psychiatric disorders including claustrophobia
  • Concurrent infections
  • Autoimmune disease
  • Neuromuscular disease
  • Contraindications to physical exercise
  • Vulnerable situations such as homelessness or incarceration preventing adherence to diet

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Instituto Nacional de Cancerología

México, Tlalpan, Mexico, 14080

Actively Recruiting

Loading map...

Research Team

D

Denisse Castro Eguiluz, PhD

CONTACT

J

Julissa Luvián Morales, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here